Franklin Resources’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.66B | Buy |
3,347,253
+2,796,121
| +507% | +$1.24B | 0.36% | 64 |
|
|
2026
Q1 | $246M | Buy |
551,132
+532
| +0.1% | +$248K | 0.06% | 274 |
|
|
2025
Q4 | $250M | Buy |
550,600
+87,646
| +19% | +$37.8M | 0.06% | 271 |
|
|
2025
Q3 | $181M | Sell |
462,954
-60,879
| -12% | -$25.4M | 0.05% | 324 |
|
|
2025
Q2 | $233M | Sell |
523,833
-178,201
| -25% | -$82.1M | 0.06% | 284 |
|
|
2025
Q1 | $340M | Sell |
702,034
-58,483
| -8% | -$27.3M | 0.1% | 214 |
|
|
2024
Q4 | $306M | Buy |
760,517
+283,684
| +59% | +$131M | 0.09% | 234 |
|
|
2024
Q3 | $231M | Sell |
476,833
-75,581
| -14% | -$36.3M | 0.06% | 271 |
|
|
2024
Q2 | $259M | Sell |
552,414
-150,645
| -21% | -$65.4M | 0.08% | 241 |
|
|
2024
Q1 | $294M | Buy |
703,059
+30,621
| +5% | +$12.9M | 0.09% | 229 |
|
|
2023
Q4 | $274M | Sell |
672,438
-82,086
| -11% | -$30.3M | 0.13% | 189 |
|
|
2023
Q3 | $262M | Sell |
754,524
-77,014
| -9% | -$26.9M | 0.13% | 187 |
|
|
2023
Q2 | $293M | Buy |
831,538
+67,629
| +9% | +$22.8M | 0.14% | 183 |
|
|
2023
Q1 | $241M | Sell |
763,909
-28,066
| -4% | -$8.42M | 0.12% | 205 |
|
|
2022
Q4 | $229M | Sell |
791,975
-140,876
| -15% | -$42.9M | 0.12% | 209 |
|
|
2022
Q3 | $270M | Sell |
932,851
-58,108
| -6% | -$16.7M | 0.15% | 173 |
|
|
2022
Q2 | $279M | Sell |
990,959
-133,797
| -12% | -$35.8M | 0.14% | 182 |
|
|
2022
Q1 | $294M | Buy |
1,124,756
+65,455
| +6% | +$15.5M | 0.12% | 211 |
|
|
2021
Q4 | $233M | Buy |
1,059,301
+192,377
| +22% | +$37.4M | 0.08% | 276 |
|
|
2021
Q3 | $157M | Sell |
866,924
-251,473
| -22% | -$49.1M | 0.06% | 353 |
|
|
2021
Q2 | $226M | Sell |
1,118,397
-45,280
| -4% | -$9.47M | 0.09% | 263 |
|
|
2021
Q1 | $250M | Sell |
1,163,677
-116,400
| -9% | -$25.6M | 0.1% | 232 |
|
|
2020
Q4 | $303M | Buy |
1,280,077
+86,217
| +7% | +$19.8M | 0.13% | 197 |
|
|
2020
Q3 | $325M | Buy |
1,193,860
+51,163
| +4% | +$14.1M | 0.16% | 172 |
|
|
2020
Q2 | $333M | Buy |
1,142,697
+50,902
| +5% | +$13.8M | 0.17% | 157 |
|
|
2020
Q1 | $260M | Sell |
1,091,795
-55,194
| -5% | -$12.7M | 0.17% | 157 |
|
|
2019
Q4 | $251M | Sell |
1,146,989
-100,879
| -8% | -$20.4M | 0.13% | 196 |
|
|
2019
Q3 | $211M | Buy |
1,247,868
+170,686
| +16% | +$30.2M | 0.11% | 222 |
|
|
2019
Q2 | $198M | Sell |
1,077,182
-82,941
| -7% | -$14.5M | 0.11% | 234 |
|
|
2019
Q1 | $213M | Sell |
1,160,123
-53,371
| -4% | -$9.86M | 0.11% | 219 |
|
|
2018
Q4 | $201M | Sell |
1,213,494
-22,441
| -2% | -$3.89M | 0.12% | 212 |
|
|
2018
Q3 | $238M | Sell |
1,235,935
-54,820
| -4% | -$9.76M | 0.12% | 212 |
|
|
2018
Q2 | $219M | Buy |
1,290,755
+163,689
| +15% | +$25.4M | 0.11% | 214 |
|
|
2018
Q1 | $184M | Sell |
1,127,066
-123,926
| -10% | -$20.2M | 0.09% | 238 |
|
|
2017
Q4 | $187M | Buy |
1,250,992
+91,078
| +8% | +$13.5M | 0.09% | 240 |
|
|
2017
Q3 | $176M | Buy |
1,159,914
+18,376
| +2% | +$2.77M | 0.09% | 248 |
|
|
2017
Q2 | $147M | Sell |
1,141,538
-51,910
| -4% | -$6.25M | 0.07% | 278 |
|
|
2017
Q1 | $131M | Sell |
1,193,448
-256,830
| -18% | -$22.6M | 0.07% | 295 |
|
|
2016
Q4 | $107M | Buy |
1,450,278
+64,159
| +5% | +$5.22M | 0.06% | 327 |
|
|
2016
Q3 | $121M | Buy |
1,386,119
+360,748
| +35% | +$34.1M | 0.06% | 307 |
|
|
2016
Q2 | $88.2M | Buy |
1,025,371
+35,356
| +4% | +$3.05M | 0.05% | 376 |
|
|
2016
Q1 | $78.7M | Buy |
990,015
+117,315
| +13% | +$10.6M | 0.04% | 404 |
|
|
2015
Q4 | $110M | Buy |
872,700
+54,691
| +7% | +$6.6M | 0.06% | 337 |
|
|
2015
Q3 | $85.2M | Sell |
818,009
-351,068
| -30% | -$45.1M | 0.04% | 396 |
|
|
2015
Q2 | $144M | Buy |
1,169,077
+222,100
| +23% | +$28M | 0.07% | 301 |
|
|
2015
Q1 | $112M | Sell |
946,977
-12,329
| -1% | -$1.48M | 0.05% | 361 |
|
|
2014
Q4 | $114M | Sell |
959,306
-162,867
| -15% | -$18.3M | 0.05% | 344 |
|
|
2014
Q3 | $126M | Sell |
1,122,173
-349,585
| -24% | -$33.3M | 0.06% | 312 |
|
|
2014
Q2 | $139M | Sell |
1,471,758
-301,215
| -17% | -$21.1M | 0.06% | 308 |
|
|
2014
Q1 | $125M | Buy |
1,772,973
+236,208
| +15% | +$18.7M | 0.06% | 318 |
|
|
2013
Q4 | $114M | Buy |
1,536,765
+133,790
| +10% | +$9.32M | 0.06% | 336 |
|
|
2013
Q3 | $106M | Buy |
1,402,975
+102,000
| +8% | +$8.12M | 0.06% | 336 |
|
|
2013
Q2 | $104M | Buy |
+1,300,975
| New | +$95.8M | 0.06% | 313 |
|
Other funds holding VRTX
VCM
VPM
Franklin Resources's VRTX Position: Q2 2026 in Review
Franklin Resources increased its Vertex Pharmaceuticals (VRTX) stake by 507% in Q2 2026, buying an estimated $1.24B and bringing the position to 3,347,253 shares worth $1.66B. The position accounts for 0.36% of the portfolio, ranked #64.
Franklin Resources first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. 1,436 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Franklin Resources held 3,347,253 shares of Vertex Pharmaceuticals worth $1.66B as of Q2 2026.
- Franklin Resources bought 2,796,121 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.24B.
- Vertex Pharmaceuticals made up 0.36% of Franklin Resources's portfolio in Q2 2026, its #64 holding.
- Franklin Resources first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,436 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.